Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (DRKS00037956) titled 'Central German Immunotherapy Registry for Thoracic Surgery' on Sept. 26.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: treatment
Primary Sponsor: Klinik fur Thoraxchirurgie, Krankenhause Martha-Maria Halle-Dolau
Condition:
C34
Malignant neoplasm of bronchus and lung
Intervention:
Group 1: Patients who underwent surgery following neoadjuvant immunochemotherapy and surgery for NSCLC
Recruitment Status: Recruiting
Date of First Enrollment: 01/08/2025
Target Sample Size: 200
Countries of Recruitment:
Germany
To know more, visit http://drks.de/search...